ISIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Isis Pharmaceuticals's account receivable for the three months ended in Dec. 2013 was $11.1 Mil. Isis Pharmaceuticals's revenue for the three months ended in Dec. 2013 was $42.2 Mil. Hence, Isis Pharmaceuticals's days sales outstanding for the three months ended in Dec. 2013 was 23.91.
Isis Pharmaceuticals's days sales outstanding increased from Dec. 2012 (2.39) to Dec. 2013 (23.91).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Isis Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2013 is calculated as
Isis Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2013 is calculated as:
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Isis Pharmaceuticals Annual Data
Isis Pharmaceuticals Quarterly Data